Development of a Wake Forest Multi-Species NHP Biorepository to Support Interdisciplinary Aging Studies

非人灵长类动物（NHP），如狒狒，食蟹猴，恒河猴和长尾猴，易受与人类相同的年龄相关的健康挑战和疾病。NHP的整体衰老轨迹也受到与人类相似的压力源和生活方式的影响。NHP研究允许受控环境，提供比人类研究更少“噪音”的纵向数据。NHP和人类之间的遗传，代谢和生理相似性使NHP的发现直接转化为我们对人类疾病过程的理解，包括这些过程的遗传易感性和早期分子指标。在该项目的R21阶段，我们将1）协调四种NHP物种的现有样本和数据，以更好地了解人类衰老的分子和细胞机制，2）实施猴样本库存和数据管理（MIDAS），这是一种LabKey Server数据管理系统，用于将组学数据和谱系数据与目标1的临床和研究数据整合。在随后的R33阶段，我们将证明这种协调的、比较性的跨物种资源在衰老研究中的独特价值，该研究使用综合组学和临床措施来量化这四种NHP在整个寿命期间肝脏和血浆中的衰老。我们将1）通过测量已知反映生物年龄的分子，包括基因表达、DNA甲基化和肝脏样本中的蛋白质，从多个实际年龄（相当于人类18-80岁）中确定每个NHP物种的生物年龄轨迹。（每种n=48（F，24; M，24））;和2）鉴定与肝特异性衰老特征相关的循环分子特征，所述肝特异性衰老特征先于与肝特异性衰老特征相关的肝特异性衰老特征。这四个NHP群体的数据和样本的对齐和协调将提供一个关键的资源，将发现转化为人类，并支持跨学科的研究整个生命周期的衰老。

Non-human primates (NHP) such as baboon, cynomolgus macaque, rhesus macaque, and vervet are susceptible to the same age-related health challenges and diseases as humans. The overall aging trajectory in NHP is also influenced by stressors and lifestyle similar to humans. Research in NHP allows for controlled environments, providing longitudinal data with less “noise” than in human studies. The genetic, metabolic and physiologic similarities between NHP and humans make findings in NHP directly translatable to our understanding of human disease processes, including genetic predispositions and early molecular indicators of these processes. In the R21 phase of this project, we will 1) harmonize existing samples and data in four NHP species that can be leveraged to better understand molecular and cellular mechanisms underlying human aging, and 2) implement the Monkey Inventory and Data management of Samples (MIDAS), a LabKey Server data management system, for integration of omic data and pedigree data with clinical and research data from Aim 1. In the subsequent R33 phase, we will demonstrate the unique value of this harmonized, comparative cross- species resource for aging studies using integrated omics and clinical measures to quantify aging in liver and plasma across the lifespan in these four NHP. We will 1) determine the biological age trajectory for each NHP species from multiple chronological ages that capture human equivalent 18-80 years, by measuring molecules known to reflect biological age including gene expression, DNA methylation, and proteins in liver samples (n=48 for each species (F, 24; M,24)); and 2) identify circulating molecular signatures that correlate with liver specific signatures of aging that precede clinical markers of aging common to the four NHP species Alignment and harmonization of data and samples for these four NHP cohorts will provide a critical resource translating discoveries to humans, and supporting interdisciplinary studies of aging across the lifespan.